TNFSF9 Antikörper (AA 101-200)

Produktnummer ABIN705056

Der Kaninchen Polyklonal anti-TNFSF9 Antikörper wird verwendet zum Nachweis von TNFSF9 in Proben von Human, Maus und Ratte. Er wurde validiert für WB, ELISA, ICC, IF (cc), IF (p), IHC (p) und IHC (fro). Der Antikörper wurde zudem unabhängig validiert.

Kurzübersicht für TNFSF9 Antikörper (AA 101-200) (ABIN705056)

Target: TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TNFSF9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Produktdetails anti-TNFSF9 Antikörper

Bindungsspezifität: AA 101-200

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human TNFSF9

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Independent Validation (IHC)

Validierung #029578 (Immunohistochemistry)

by: Immunohistochemistry Core, NYU Langone

No.: #029578

Datum: 18.01.2014

Chargennummer: 999892W

Validierte Anwendung: Immunohistochemistry

Positivkontrolle: Human liver

Negativkontrolle: Human placental decidual cells

Bewertung: Signal was detected in positive control tissue and not in negative control tissue.

Validierungsbilder

Figure 1: TNFSF9 staining of human liver (brown). Counterstain in blue.

Figure 2: Isotype control staining of human liver (brown). Counterstain in blue.

Figure 3: Secondary only staining of human liver (brown). Counterstain in blue.

Figure 4: TNFSF9 staining of human placenta (brown). Counterstain in blue.

Figure 5: Isotype control staining of human placenta (brown). Counterstain in blue.

Figure 6: Secondary only staining of human placenta (brown). Counterstain in blue.

Protokoll

Primärantikörper:

• Antibody: Tumor necrosis factor ligand superfamily member 9 (TNFSF9)
• Catalog number: ABIN705056
• Lot number: 999892W

Sekundärantikörper:

• Antibody: Biotinylated goat anti-rabbit/anti-mouse (Kit)
• Lot number: D05923BA

Full Protocol:

• Immunohistochemistry was performed on a Ventana NexES automated platform, instrument manufacturer specific reagents are italicized.
• 1. Slides were preheated in convection oven at 60°C for 30 minutes
• 2. Deparaffinization procedure: - 3 changes of Xylene, 5 minutes each - 3 changes of 100% Ethanol, 3 minutes each - 3 changes of 95% Ethanol, 3 minutes each - Rinsed in distilled water, 3 changes
• 1. Heat retrieval procedure - Slides retrieved in 10.0 mM Citrate, pH6.0 in a 1000W microwave oven (~100°C) for 15 minutes. - Slides were allowed to cool (in citrate) for 30 minutes. - Slides were washed x 3 in Distilled water
• 1. NexES instrument procedure, iVIEW DAB paraffin protocol (*abridged*): - Slide chamber warmed to 37°C
• 1. Slides rinsed with *reaction buffer* x 3
• 1. *iVIEW Inhibitor (H2O2)* applied and incubated for 4 minutes
• 1. Slides rinsed with *reaction buffer*
• 1. Antibody Application - Primary antibody diluted 1:250 in PBS (100 microliters applied/slide) - Ventana Isotype control applied neat - Slides incubated overnight at room temperature (~12 hours ~25°C)
• 1. Slides rinsed with *reaction buffer* x3
• 1. *iVIEW Biotinylated IgG* applied and incubated for 8 minutes
• 1. Slides rinsed with *reaction buffer*
• 1. *iVIEW Streptavidin-Horseradish Peroxidase* applied and incubated for 8 minutes
• 1. Slides rinsed with *reaction buffer*
• 1. *iVIEW DAB/H2O2* applied and incubated for 8 minutes
• 1. Slides rinsed with *reaction buffer*
• 1. *iVIEW Copper* applied and incubated for 4 minutes
• 1. Slides rinsed with *reaction buffer*
• 1. Slides washed in Dawn Detergent/tap water
• 1. Counterstain Procedure - Hematoxylin (Leica 560 MX) 30 seconds - Slides washed in tap water, 1 minute - Decolorized (10% Acetic Acid in 70% ethanol), 1 minute - Slides washed in tap water, 1 minute - Bluing (Austin Clear Ammonia), 1 minute - Slides washed in tap water, 1 minute
• 1. Dehydration/coverslipping procedure: - 3 changes of 95% Ethanol, 3 minutes each - 3 changes of 100% Ethanol, 3 minutes each - 3 changes of Xylene, 5 minutes each - Mounted with Permount
• 1. Imaging: Leica SCN 400F Whole Slide Scanner with Digital Image Hub and Leica Slidepath software

Anmerkungen:

• Deviations from protocol/procedure supplied by manufacturer:
• Step 1: Heated tissue 60°C for 30 minutes; manufacturer heats for 45 minutes.
• Step 2: No ethanol wash was performed during deparaffinization; manufacturer includes 1 wash of 80% ethanol for 3 minutes.
• Step 3.1: Slides heated for 15 minutes; manufacturer provides a range of 15-20 minutes.
• Step 3.2: Slides cooled for 30 minutes; manufacturer cools for 20 minutes.
• Step 4: Italicized reagents and incubation time are fixed instrument parameters.
• Step 5: Secondary species-specific serum block not used; manufacturer blocks with 5% normal goat serum for 2 hours.
• Step 8.1: Antibody diluted in PBS at 1:250; manufacture recommends dilution range (1:100-1:500). No primary antibody diluent recommended.
• Step 8.2.1: Primary antibody incubated at room temperature overnight; manufacturer incubates overnight 4°C with agitation.
• Tissue Interpretation (limited): • TNFSF9: Under the staining parameters described above, placenta was weakly cytoplasmic positive (trophoblastic and decidua cells). Liver hepatocytes were weakly stained. Substantial signal detected in limited number of other tissues, including kidney, prostate, and skin.
• • I-NC (Isotype negative control): No signal detected
• • B-NC (Blank negative control): No signal detected
• Signal Localization: - Signal to noise was adequate with predominately cytoplasmic subcellular localization observed. Nuclear staining was rare and no distinct membrane signal was detected.

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu TNFSF9

Target: TNFSF9 (Tumor Necrosis Factor (Ligand) Superfamily, Member 9 (TNFSF9))

Andere Bezeichnung: TNFSF9/CD137L

Hintergrund:

Synonyms: CD137L, 4-1BB-L, Tumor necrosis factor ligand superfamily member 9, 4-1BB ligand, 4-1BBL, TNFSF9

Background: Cytokine that binds to TNFRSF9. Induces the proliferation of activated peripheral blood T-cells. May have a role in activation-induced cell death (AICD). May play a role in cognate interactions between T-cells and B-cells/macrophages.

Gen-ID: 8744

UniProt: P41273

Pathways: Activated T Cell Proliferation, Cancer Immune Checkpoints